Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) shares saw an uptick in trading volume on Wednesday . 1,202,860 shares were traded during trading, an increase of 11% from the previous session's volume of 1,088,274 shares.The stock last traded at $0.81 and had previously closed at $0.77.
Elite Pharmaceuticals Trading Up 10.7%
The company has a quick ratio of 1.90, a current ratio of 3.27 and a debt-to-equity ratio of 0.12. The firm has a market cap of $792.72 million, a price-to-earnings ratio of -37.10 and a beta of 0.17. The business has a 50 day moving average of $0.51 and a 200 day moving average of $0.50.
Elite Pharmaceuticals Company Profile
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Articles
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
